Curamir Therapeutics (Series A)

Funding Details

Awarder: Inbox
Date Award: September 23, 2019
Vertical: Biotechnology
Funding URL: View Funding Page
Funding Amount:: $10,000,000

Company Info

Founders: Henry Chen
Company Description: Curamir is developing innovative therapeutics based on its proprietary miRNA engineering platform and insights into cancer biology, aiming to address unmet needs to overcome drug resistance and toxicity associated with current oncology therapies.
Market: Oncology
Location: Lexington, MA, USA
Coinvestors: Delos Capital

Links

Website

Back to Home Back to Biotechnology Deals View Funding Announcement